In this video, Dr Karl Doghramji, describes the various agents available for managing sleep disorders and discusses the adverse effects associated with over-the-counter, nutraceutical, and prescription sleep aids.
US Psychiatric & Mental Health Congress 2014
Standardized, quantifiable outcome measures exist for most major psychiatric disorders, yet they are rarely used in routine clinical practice. This article identifies the rationale for using psychiatric scales.
In this podcast, Drs Shah and Lustig provide a summary of their presentation at the 2014 Psychiatric and Mental Health Congress and explain the process, rationale, and application of the numerous changes to the CPT codes.
How can we get even better at customizing treatment for our patients and thereby achieve improved outcomes? How do we avoid becoming relegated to mere brokers of psychopharmacologic commodities? A few thoughts in this brief communication.
Non-adherence to prescribed medication by patients with psychiatric disorders is one of the greatest challenges reported by clinicians.
A significant number of patients have some degree of personality pathology that can interfere with treatment, whether they receive medication or some form of psychotherapy. But how can clinicians develop a strong therapeutic alliance with patients who have personality disorders? An expert explains.
A comprehensive adjustment to life after having had a psychotic episode and diagnosis of schizophrenia is a relatively new concept. An expert describes the post-psychotic adjustment process
We have medications that can affect serotonin, norepinephrine, and—to a lesser extent—dopamine. Many other neurotransmitters are involved with mood disorders, but we have no medications yet to target them. Neurostimulation offers a non-systemic somatic approach to depression, often with an improved side effect profile. More in this Q&A.
It is absolutely essential that every person who has bipolar disorder be screened for risk factors related to metabolic syndrome and diabetes and traditional risk factors like overweight and eating habits. More in this podcast.
The lay press has focused a lot of attention on the use of ketamine as a potentially rapidly acting treatment for depression. But are psychiatrists really ready to offer ketamine as a treatment alternative for mood disorders? An expert weighs in.